Avedro Raises $32M From OrbiMed and InterWest

November 15, 2015 | Herzliya-based OrbiMed and Silicon Valley-based InterWest led a $32 million round of funding for medical eye device company Avedro. The additional capital strengthens Avedro’s balance sheet as it continues to expand global distribution of its ophthalmological KXL corneal cross-linking platform and commences commercialization outside of the United States of its Mosaic System. The Mosaic System performs a procedure called PiXL™ (Photorefractive Intrastromal Cross-Linking) which has the potential to deliver non-surgical correction of myopia, and improve cataract surgery outcomes.